Just Other Articles

They say that in literature everything has already been said (written). If you want to write

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

a novel, you should differentiate on style rather than on anything else.

And this is not l

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ess true in business. Our “Style Compass” seems familiar with elements from the model of My

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ers-Briggs and also with the Competing Values Framework. And perhaps with many other concept

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s.

Recently I found another reference with similarities; the so-called Left-Hand/Right-Hand

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

model being the brainchild of Professor John Donovan of MIT. This model is about managing o

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

r leading innovations:

...Its main tenet is that all organizational functions ca

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

n be divided into two categories-the standard quotidian efforts at status quo maintenance an

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

d risk minimization, and the riskier ventures into new fields or endeavours. The former is l

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

abelled the right-hand, while the latter is the left-hand. It is within this Left-Hand sect

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

or that innovation occurs, through the dual paths of employing revolutionary processes and l

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

eading customers. To delve into new territory, the organization must lead its customers, rat

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

her than solely listening and responding to their wants and concerns. (www.cellexchange.

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

com/pdfs/InnovationandCollaboration.pdf)

If you are interested in culture, values

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

, personal preferences, organizational Style, etc, you should use what is close to what is a

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

lready known in the organization. More important is that you use one concept from start to f

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

inish or even longer. Because the topic about managing innovation and stabilizing business s

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

uccess is of all times.

If you are lucky to have ever produced a film like Shrek (innovatio

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

n) you want to stabilize this success with a sequel Shrek 2, Shrek 3, etc...

Most topics in

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/34822/justotherarticles-What-to-Do-When-Everything-Has-Already-Been-Said.html">What to Do When Everything Has Already Been Said</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/34822/justotherarticles-What-to-Do-When-Everything-Has-Already-Been-Said.html]What to Do When Everything Has Already Been Said[/url]

The 3 Ps — picture or preferred future, principles, and purpose — are critically important questions. Our answers to these three basic questions define the team and/or organizational culture we are trying to create.

How about the newspaper ad with the picture of the funeral home building and how they have been around for 85 years? Benefit?

Have you ever wondered if you would make a good franchisee? Do you possess the skills and traits that are needed to be a successful franchisee?

Tags

Links

Just Other Articles - What to Do When Everything Has Already Been Said

Related Articles: